Treatment of Severe Pulmonary Hypertension with Inhaled Iloprost [5]

Annals of Internal Medicine

Volumn 139, Issue 4, 2003, Pages 306-

  Leuchte, H H ^a   Baumgartner, R A ^a   Behr, J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; ILOPROST; IMIGLUCERASE; OXYGEN; ANTIHYPERTENSIVE AGENT; VASODILATOR AGENT;

ADULT; BICYCLE ERGOMETER; CASE REPORT; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GAUCHER DISEASE; HEART CATHETERIZATION; HUMAN; LETTER; LYSOSOME STORAGE DISEASE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SPIROMETRY; VASCULAR RESISTANCE; WALKING; INHALATIONAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ADULT; ANTIHYPERTENSIVE AGENTS; FEMALE; GAUCHER DISEASE; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; VASODILATOR AGENTS;

EID: 0141789615     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-139-4-200308190-00025     Document Type: Letter

References (4)

1. Elstein D, Klutsrein MW, Lahad A, Abrahamov A, Hadas-Halpern I, Zimran A. Echocardiographic assessment of pulmonary hypertension in Gaucher's disease. Lancet. 1998;351:1544-6. [PMID: 10326537]
2. Hoeper MM, Schwarze M, Ehlerding S, Adler-Schuermeyer A, Spiekerkoetter E, Niedermeyer J, et al. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med. 2000;342:1866-170. [PMID: 10861321]
3. Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med. 1996;124:820-4. [PMID: 8610951]
4. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;334:296-302. [PMID: 8532025]